Also trades as: ZIVOW (NASDAQ) · $vol 0M
ZIVO OTC
ZIVO Bioscience, Inc.
1W: +25.8%
1M: +5.1%
3M: -20.9%
YTD: -58.1%
1Y: -67.5%
3Y: -41.4%
5Y: -87.3%
$4.15
+0.61 (+17.17%)
Weekly Expected Move ±19.9%
$3
$3
$4
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$157K
+468.6% ▲
Gross Profit
$49K
+321.6% ▲
Operating Income
-$13M
-84.0% ▼
Net Income
-$13M
-72.1% ▼
EPS (Diluted)
$-3.92
+14.8% ▲
EBITDA
-$13M
-84.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $20K | $0 | $0 | $28K | $157K |
| YoY Growth | +0.0% | -100.0% | +0.0% | +0.0% | +468.6% |
| Cost of Revenue | $0 | $0 | $0 | $16K | $108K |
| Gross Profit | $20K | $0 | $0 | $12K | $49K |
| Gross Margin | 100.0% | — | — | 42.0% | 31.1% |
| R&D Expenses | $4M | $2M | $2M | $1M | $3M |
| SG&A Expenses | $5M | $7M | $6M | $6M | $10M |
| Operating Expenses | $9M | $9M | $9M | $7M | $13M |
| Operating Income | -$9M | -$9M | -$9M | -$7M | -$13M |
| Operating Margin | -42778.4% | — | — | -26267.7% | -8498.9% |
| Interest Expense | $550K | $233K | $13K | $514K | $23K |
| Income Before Tax | -$9M | -$9M | -$9M | -$8M | -$13M |
| Tax Expense | $0 | $233K | $0 | $0 | $0 |
| Net Income | -$10M | -$9M | -$9M | -$8M | -$13M |
| Net Margin | -48278.9% | — | — | -28127.2% | -8513.4% |
| EPS (Diluted) | $-11.41 | $-7.39 | $-5.57 | $-4.60 | $-3.92 |
| EBITDA | -$550K | -$9M | -$9M | -$7M | -$13M |
| Shares Outstanding | 846212 | 1M | 2M | 2M | 3M |